CD44 is a transmembrane glycoprotein reported to be reduced in urine in conditions such as acute kidney transplant rejection and IgA nephropathy [29,30], which aligns with our findings where it was reduced but positively associated with eGFR in the CKD group [5,10]. The gene discussed is CD44; the disease is IgA glomerulonephritis.